Patent · US Active

Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins

US9902783B2 · kind B2 · utility

0Cited by
7References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 23, 2016
Grant dateFeb 27, 2018
Priority date—
Expiry dateMay 23, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An antibody comprising an antigen recognition region which comprises CDR amino acid sequences set forth in SEQ ID NO: 7, 8, 9, 10, 11 and 12.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.